Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-β. (Q45807781)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207971%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

title

Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-β (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207971%20AND%20SRC:MED&resulttype=core&format=json

relapsing-remitting multiple sclerosis

19 February 2020

main subject

0 references

author

Rodica Bălaşa

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207971%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Zoltan Bajko

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207971%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Adina Huţanu

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207971%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

publication date

3 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207971%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

19 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207971%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207971%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207971%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

885-890

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207971%20AND%20SRC:MED&resulttype=core&format=json

Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis

19 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

Interferon-β exacerbates Th17-mediated inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

Clinical markers of therapeutic response to disease modifying drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

Interferon-beta responders and non-responders. A biological approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

IFN-beta inhibits human Th17 cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

Interleukin-17--extended features of a key player in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

Multiple sclerosis pharmacogenomics: maximizing efficacy of therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

Appearance and disappearance of neutralizing antibodies during interferon-beta therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

Development of biomarkers in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

A rush to judgment on Th17

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512468497

21 January 2018

Identifiers

DOI

10.1177/1352458512468497

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23207971%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference